condylomata acuminata


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to condylomata acuminata: molluscum contagiosum

condyloma

 [kon″dĭ-lo´mah] (pl. condylo´mata) (L.)
an elevated wartlike lesion of the skin. adj., adj condylo´matous.
condyloma´ta acumina´ta (sing. condylo´ma acumina´tum) Sexually transmitted venereal papillomatous lesions caused by the human papillomavirus. The incubation period is one to three months. The growths are usually pinkish and occur around the cervix, vulva, perineum, anus and anal canal, urethra, and glans penis. They are often treated with weekly applications of podophyllum resin, 10 to 25 per cent in tincture of benzoin or by application of trichloroacetic acid. Especially resistant warts or extensive involvement may require electrocautery, cryosurgery, or recombinant interferon alfa-2b or alfa-n3. Called also genital or venereal warts. (See Atlas 2, Part H.)
flat condyloma condyloma latum.
giant condyloma Buschke-Löwenstein tumor.
condyloma la´tum a wide, flat, syphilitic condyloma occurring on moist skin, especially around the genitals or anus.

condylomata acuminata

Soft, pinkish, cauliflower-like warts on the genitals caused by papovaviruses-the same viruses that cause other kinds of warts—and spread by sexual intercourse.

Condylomata acuminata

Another name for genital warts.
Mentioned in: Genital Warts
References in periodicals archive ?
In the United States it has been cleared for use by the FDA for chronic viral hepatitis B, chronic viral hepatitis C, malignant melanoma, hairy cell leukemia, AIDS- related Kaposi's sarcoma and condylomata acuminata (venereal warts).
INTRON A is also marketed in the United States for the treatment of chronic hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma, condylomata acuminata (venereal warts) and as adjuvant use in patients with malignant melanoma.
marketing clearance for treating hairy cell leukemia, AIDS-related Kaposi's sarcoma, condylomata acuminata, and chronic hepatitis B and C.
Schering-Plough's alpha interferon, marketed as INTRON(R) A, is an injectable antiviral/anticancer product currently approved in the United States for five indications: hepatitis B, hepatitis C, hairy cell leukemia, AIDS-related Kaposi's sarcoma and condylomata acuminata (venereal warts).